Specifically, SAB has been shown to regulate glycolysis through the PI3K/AKT/HIF-1α signaling pathway, thereby inhibiting metabolic reprogramming and tumor growth in a hamster oral cancer model (Wei et al., 2018). The gene discussed is HIF1A; the disease is neoplasm.